Chih Huang Ho

PAC-LINK Management Corp. (PAC-LINK) is the venture capital subsidiary of Taiwan-based Yulon Group, a major automotive assembly and textiles industrial group with businesses in nine provinces of China, Taiwan, and the Philippines. Founded in 1998, PAC-LINK invests in dynamic companies in Greater China and North America. The firm is headquartered in Taipei and also has offices in Shanghai and Palo Alto in the US. They manage venture capital funds covering a wide range of industries, working closely with company managers to minimize risks, maximize opportunities, and help build rapidly growing businesses.

Pac-Link BioVenture Fund I invests in the life science industry, biotechnology and pharmaceutical sectors in Greater China. It provides financing for early, expansion, and later stage capital requirements. The fund invests in the range of $2 million - $10 million per transaction.

TWi Pharmaceuticals, Inc. operates as a technology-based special pharmaceutical company. The firm engages in the development and commercialization of high barrier generics drugs. Its products include donepezil hydrochloride tablets, megestrol acetate oral suspension, hydroquinone cream, guanfacine extended-release tablets and nifedipine extended-release tablets. The company was founded by Chih Ming Chen on December 1, 1997 and is headquartered in Taipei, Taiwan.

Phalanx Biotech Group, Inc. manufactures and sells DNA microarrays. The firm specializes in microarrays for gene expression profiling and microRNA expression profiling. The company was founded in 2002 and is headquartered in Hsinchu, Taiwan.